Trial intelligence / Profile preview

Montelukast for Pediatric OSAS

NCT01027806Phase 4Terminated

Sponsor
University of Chicago
Start
Jul 2010
Primary completion
Aug 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of montelukast in obstructive sleep apnea syndrome (OSAS), sponsored by University of Chicago. Started Jul 2010; status: terminated.

02

Drugs

montelukast
03

Conditions

obstructive sleep apnea syndrome (OSAS)

Beyond the preview

Go deeper on NCT01027806.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01027806.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call